Sullivans Brands has been Acquired by ICV Partners
Fort Point Capital has sold Sullivans Brands to ICV Partners.
Based in Sioux Falls, South Dakota, Sullivans is a market leading designer and distributor of everyday and seasonal home décor, garden and outdoor products. Sullivans leverages its reputation for quality, distinctive designs and customer care to serve a diverse and loyal customer base of independent gift and décor retailers, leading national accounts and the e-commerce channel, including direct-to-consumer.
ICV Partners is a Miami-based private equity firm that partners with businesses in the business service, food and beverage, consumer and healthcare sectors.
Fort Point Capital is a private equity firm based in Boston, Massachusetts, that partners with growth-oriented, lower-middle-market companies.
Oaklins TM Capital in the US served as the exclusive financial advisor to Sullivans Brands, a portfolio company of Fort Point Capital, in its sale to ICV Partners.
Brooke Ablon
Partner and co-founder, Fort Point Capital
Contáctese con el equipo de la transacción
Philip S. Krieger
Oaklins TM Capital
Transacciones relacionadas
OBI Group has acquired the OBI and individual DIG stores from Migros
As part of a strategic review, Migros has decided to divest its DIY business, which included several “Do It + Garden” and “OBI” locations. Migros had operated the Swiss OBI stores as a franchisee. In OBI Group Holding, Migros has found the ideal partner to ensure continuity for both its customers and employees.
Ver másDen Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Ver másXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Ver más